Citation Impact
Citing Papers
Potent Induction of Tumor Immunity by Combining Tumor Cryoablation with Anti–CTLA-4 Therapy
2011 StandoutNobel
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
2013 StandoutNobel
New Technology and Health Care Costs — The Case of Robot-Assisted Surgery
2010 Standout
Percutaneous cryoablation of hepatic tumors: long-term experience of a large U.S. series
2016
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Inventory of prostate cancer predictive tools
2008
Clinical development and potential of photothermal and photodynamic therapies for cancer
2020 Standout
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 Standout
Current Status of HIFU and Cryotherapy in Prostate Cancer – A Review
2006
CTLA-4 blockade synergizes with cryoablation to mediate tumor rejection
2012 StandoutNobel
The molecular basis of cryosurgery
2005
Pathological and molecular aspects of prostate cancer
2003
Up-regulation of hypoxia-inducible factor 1α is an early event in prostate carcinogenesis
2004 StandoutNobel
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer
2003 Standout
Significance of small foci of Gleason score 7 or greater prostate cancer on needle biopsy
1999
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity
2009 Standout
Initial assessment of safety and clinical feasibility of irreversible electroporation in the focal treatment of prostate cancer
2014
Thermal ablation of tumours: biological mechanisms and advances in therapy
2014 Standout
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
2005 Standout
Selective estrogen receptor modulators for the chemoprevention of prostate cancer
2001
Incomplete glandular ablation after salvage cryotherapy for recurrent prostate cancer after radiotherapy
2003
The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
2015 Standout
EAU Guidelines on Prostate Cancer
2007 Standout
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
Quantitative nuclear grade (QNG): A new image analysis-based biomarker of clinically relevant nuclear structure alterations
2000
The roles of PTEN in development, physiology and tumorigenesis in mouse models: a tissue-by-tissue survey
2008 StandoutNobel
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Treatment of Clinically Localised Disease
2010
Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancer
2014 StandoutNobel
Should each core with prostate cancer be assigned a separate gleason score?
2003
Applications of machine learning in drug discovery and development
2019 Standout
Gleason score 7 prostate cancer: a heterogeneous entity? correlation with pathologic parameters and disease-free survival
2000
Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic
2018 Standout
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
2006 Standout
Comparative effectiveness of cryotherapy vs brachytherapy for localised prostate cancer
2011
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013
2013 Standout
Presalvage prostate‐specific antigen (PSA) and PSA doubling time as predictors of biochemical failure of salvage cryotherapy in patients with locally recurrent prostate cancer after radiotherapy
2006 Standout
A CATALOG OF PROSTATE CANCER NOMOGRAMS
2001
Characterizing Clinically Significant Prostate Cancer Using Template Prostate Mapping Biopsy
2011
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
TNF-α–based accentuation in cryoinjury—dose, delivery, and response
2007
Photodynamic Therapy by Means of 5-ALA Induced PPIX in Human Prostate Cancer – Preliminary Results
2003
Prognostic and predictive factors and reporting of prostate carcinoma in prostate needle biopsy specimens
2005
Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study
2019
Critical Review of Prostate Cancer Predictive Tools
2009
A randomized trial of external beam radiotherapy versus cryoablation in patients with localized prostate cancer
2009
Systematic Review: Comparative Effectiveness and Harms of Treatments for Clinically Localized Prostate Cancer
2008
Irreversible Electroporation: Implications for Prostate Ablation
2007
Radical Nephrectomy for pT1a Renal Masses May be Associated With Decreased Overall Survival Compared With Partial Nephrectomy
2008
SQUID-Detected Magnetic Resonance Imaging in Microtesla Fields
2007 StandoutNobel
RESULTS OF SALVAGE CRYOABLATION OF THE PROSTATE AFTER RADIATION: IDENTIFYING PREDICTORS OF TREATMENT FAILURE AND COMPLICATIONS
2001
Image-Guided Prostate Cryosurgery: State of the Art
2001
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
Breast Cancer in Men
2002 Standout
Works of Duke Bahn being referenced
Cryosurgery for prostate cancer: improved glandular ablation by use of 6 to 8 cryoprobes
1999
Focal Cryotherapy for Clinically Unilateral, Low-Intermediate Risk Prostate Cancer in 73 Men with a Median Follow-Up of 3.7 Years
2012
Group Consensus Reports from the Consensus Conference on Focal Treatment of Prostatic Carcinoma, Celebration, Florida, February 24, 2006
2007
Is radical prostatectomy primarily a surgical debulking procedure?
1996
Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate
2001
Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer
2002
Focal Prostate Cryoablation: Initial Results Show Cancer Control and Potency Preservation
2006
Best Practice Statement on Cryosurgery for the Treatment of Localized Prostate Cancer
2008
An Algorithm for Predicting Nonorgan Confined Prostate Cancer Using the Results Obtained from Sextant Core Biopsies with Prostate Specific Antigen Level
1996